Jan-Mar Earnings
Sun Pharma consol PAT rises to INR 27.14 bln, but misses estimates
This story was originally published at 15:06 IST on 22 May 2026
Register to read our real-time news..jpg&w=1920&q=75 "Jan-Mar-Earnings-Sun-Pharma-consol-PAT-rises-to-INR-27-14-bln-but-misses-estimates")
MUMBAI - Sun Pharma Ltd.’s consolidated net profit for Jan-Mar rose to INR 27.14 bln from INR 21.50 bln in the year-ago period. The bottom line, however, missed the analysts estimates of INR 28.09 bln for the period. The revenue of the company rose to INR 146.12 bln from INR 129.59 bln a year ago and was above the estimate of INR 145.90 bln.
* Sun Pharma Jan-Mar consol net profit INR 27.14 bln
* Analysts saw Sun Pharma Jan-Mar consol net profit at INR 28.09 bln
* Sun Pharma Jan-Mar consol revenue INR 146.12 bln
* Analysts saw Sun Pharma Jan-Mar consol revenue at INR 145.90 bln
* Sun Pharma Jan-Mar consol net profit INR 27.14 bln vs INR 21.50 bln yr ago
* Sun Pharma Jan-Mar consol revenue INR 146.12 bln vs INR 129.59 bln yr ago
* Sun Pharma to pay INR 5 per share final dividend
* Sun Pharma FY26 consol net profit INR 114.79 bln vs INR 109.29 bln yr ago
* Sun Pharma Jan-Mar consol EBITDA INR 39.54 bln, up 6.4% on year
* Sun Pharma FY26 consol revenue INR 584.62 bln vs INR 525.78 bln yr ago
To read more please subscribe
Share this Story:
